The present study was designed to screen the genetic polymorphisms and expression profiling of and genes in brain tumor patients. The amplification refractory mutation system PCR technique (ARMS-PCR) was used for mutation analysis using 300 blood samples of brain tumor patients and 300 overtly healthy controls. For expression analysis, 150 brain tumor tissue samples along with adjacent uninvolved/normal tissues (controls) were collected.
View Article and Find Full Text PDF